ArticleFrontiers in pharmacology2024

Case report: Favorable efficacy of combined afatinib and anlotinib treatment in a lung adenocarcinoma patient harboring uncommon

Yueming He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.